[go: up one dir, main page]

EP1948302A2 - Fortschrittliches kardiales lebensunterstützendes gerät und verfahren - Google Patents

Fortschrittliches kardiales lebensunterstützendes gerät und verfahren

Info

Publication number
EP1948302A2
EP1948302A2 EP06844282A EP06844282A EP1948302A2 EP 1948302 A2 EP1948302 A2 EP 1948302A2 EP 06844282 A EP06844282 A EP 06844282A EP 06844282 A EP06844282 A EP 06844282A EP 1948302 A2 EP1948302 A2 EP 1948302A2
Authority
EP
European Patent Office
Prior art keywords
clock
minutes
patient
pediatric
cpr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06844282A
Other languages
English (en)
French (fr)
Inventor
Gregory Blomquist
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP1948302A2 publication Critical patent/EP1948302A2/de
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/38Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
    • A61N1/39Heart defibrillators
    • A61N1/3904External heart defibrillators [EHD]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/38Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
    • A61N1/39Heart defibrillators
    • A61N1/3904External heart defibrillators [EHD]
    • A61N1/39044External heart defibrillators [EHD] in combination with cardiopulmonary resuscitation [CPR] therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/38Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
    • A61N1/39Heart defibrillators
    • A61N1/3993User interfaces for automatic external defibrillators

Definitions

  • the preferred embodiment of the present invention relates to a computer hardware and software based system used during the performance of cardiac life support procedures.
  • CVD cardiovascular disease
  • the answering service typically assures the floor secretary that if the doctor doesn't call back in 20 minutes they will notify the doctor again. Meanwhile, the patient may stop breathing.
  • a responder who remembers the ACLS procedure will be critically needed in the patient's room. However, it is often the case that no one in the room works in the ER or has kept up with the latest changes in the ACLS protocols. As a result, the patient may die, notwithstanding the heroic efforts of the responders who, unfortunately have inadequate knowledge and experience of ACLS. What is desired is a method and apparatus operable to guide responders, via audible prompts and visual cues, through the medications, dosages and proper timing sequences required during a cardiac arrest event, according to the ACLS protocols.
  • a preferred embodiment of the present invention comprises an ACLS method and apparatus operable to guide responders, via audible prompts and visual cues, through the proper procedures to be applied to a patient during a cardiac arrest.
  • a preferred embodiment of the present invention can be located on a conventional hospital crash cart which stores the emergency equipment and medications, or can be hardware and application software, the application software being loadable and loaded into computer hardware having a central processing unit (CPU), memory, input/output means such as a keyboard, mouse, touchpad, trackball, speaker, buzzer, illuminated indicators, video display and the like, data busses and operating software and drivers.
  • the computer hardware can be a mainframe, personal computer (PC), terminal, tablet PC, laptop PC, personal digital assistant (PDA), and the like.
  • Input to the computer hardware/software can be facilitated via keystrokes, screen taps, button or switch activation, voice recognition, mouse clicks, biometric recognition and the like.
  • a preferred embodiment of the present invention advantageously makes the ACLS procedures, such as types and dosages of medications to administer, and sequence of performing actions (such as cardiac pulmonary resuscitation (CPR)) on the patient easier to acknowledge and follow.
  • CPR cardiac pulmonary resuscitation
  • FIGS. IA- ITTT provide a flow chart of an exemplary method of the present invention as would be administered to an adult patient;
  • FIG. 2 is a block diagram of a computer based exemplary apparatus adapted to perform methods of the present invention
  • FIGS. 3A-3C are three views of an exemplary apparatus adapted to perform the methods of the present invention adapted to be installed on a hospital crash cart; and
  • FIG. 4 is an exemplary apparatus adapted to perform the methods of the present invention in the form of a PDA. References in the detailed description correspond to like references in the Figures unless otherwise noted. Like numerals refer to like parts throughout the various Figures.
  • the preferred embodiment of the present invention comprises an ACLS method and apparatus operable to guide responders, via audible prompts and visual cues, through the proper procedures to be applied to a patient during a cardiac arrest.
  • a preferred embodiment of the present invention preferably comprises application software run on computer hardware, the application software being loadable and loaded into computer hardware having a central processing unit (CPU), memory, input/output means such as a keyboard, mouse, touchpad, touch screen trackball, speaker, buzzer, illuminated indicators, printer, video display, ports (such as serial, parallel, USB, infrared (IR), and wireless) and the like, data busses, a power supply and regulation circuit, and operating software and drivers.
  • CPU central processing unit
  • memory input/output means
  • input/output means such as a keyboard, mouse, touchpad, touch screen trackball, speaker, buzzer, illuminated indicators, printer, video display, ports (such as serial, parallel, USB, infrared (IR), and wireless) and the like, data busses, a power supply and
  • the computer hardware can be a mainframe, personal computer (PC), mobile terminal, thin client terminal, tablet PC, laptop PC, personal digital assistant (PDA) (as seen in Figure 4), and the like.
  • Input to the computer hardware/software can be facilitated via keystrokes, screen taps, button or switch activation, voice recognition, mouse clicks, biometric recognition and the like.
  • An embodiment of the present invention is in the form of at least one computer readable medium and processor instructions contained on the at least one computer readable medium.
  • the processor instructions contain the algorithms to be used during ACLS procedures, such algorithms generally in the form of decision trees.
  • a decision tree is a set of decisions and their possible consequences used to create a plan to reach an objective, in this case the resuscitation of a patient.
  • a decision tree is a predictive model that is a mapping of observations about a patient to conclusions about the patient's eventual outcome.
  • the processor instructions are configured to be readable from the at least one computer readable medium by at least one processor and thereby cause the at least one processor to determine when to provide prompts, accept inputs, start timers, and indicate the status of events.
  • FIG. 3 A is a front view of apparatus 300 having audio output 301, touch sensitive digital display 302 and digital clock displays 303.
  • Figure 3B is a top view showing digitals clock displays 303 from the top and input buttons 304 for responding to prompts and commands of the apparatus 300.
  • Figure 3C is a side view of apparatus 300.
  • a preferred embodiment of the present invention comprises an apparatus for use in performing ACLS procedures having at least one prompting means for obtaining information from a user; at least one input means for obtaining user responses to information prompts; at least one timing means for obtaining timing information based on elapsed time or the temporal occurrence of events; a logic means operable to determine a decision path selection based on user responses to information prompts and timing information; and at least one output means for providing communication cues to guide responders through the proper procedures to be applied to a patient during a cardiac arrest based on output from the logic means.
  • the operation of the computer hardware being directed via the software, can be changed by upgrading or modifying the software.
  • Such changes can be made to the software, via a hardware port, when, for example, ACLS procedures are improved or changed or as new medications and dosages are introduced.
  • the scope of the present invention is meant to at least encompass the ability to make such changes.
  • the preferred embodiment of the present invention advantageously makes the ACLS procedures, such as types and dosages of medications to administer, and sequence of performing actions (such as cardiac pulmonary resuscitation (CPR)) on the patient easier to acknowledge and follow.
  • CPR cardiac pulmonary resuscitation
  • the apparatus is activated by means of an on-off switch.
  • a touch screen prompts the nurse to initiate a specific algorithm by choosing whether the patient is an adult or child, and within seconds the first audible command is issued from the apparatus at a volume that is suitable for the responders to hear. Once the first command is followed, the nurse then touches the screen to inform the apparatus of such fact, and a first timer of a plurality of timers, is activated. The first timer counts down to a certain level (such as zero), after which an addition command is given.
  • Additional timers e.g., a second timer, third timer, fourth timer, of the plurality of timers operate concurrently and/or consecutively, each providing a precise determination of when an addition event in the ACLS procedure is to occur or an action to be commanded.
  • Such actions and events can include, among other things, the dosage and administration of medications, performance of CPR, and the monitoring of patient vital signs. If the patient's conditions changes during the process of resuscitation, the method and apparatus is adapted to prompts the nurse for the change of condition and the method causes the screen selections to change accordingly.
  • the scenario could involve a physician who is not well-versed in ACLS procedures using a PDA that has been loaded with application software that is adapted to perform the methods of a preferred embodiment of the present invention.
  • the audible and visual prompts can be in English or in any other language which is best suited to the location and language of the responders.
  • a preferred embodiment of the present invention is adapted to guide responders through a difficult situation by instructing them in what to do in sequential order and by timing the events with precision. In this manner, proper medications in the correct dosages are administered and actions are taken at the proper time, thus improving the probability of survival of the patient.
  • a preferred embodiment of the present invention is providing audible prompts to the responders about the timely nature of administering medicine and at what intervals.
  • An additional aspect of a preferred embodiment of the present invention is the use of medications in color-coded packages medications in combination with the apparatus and method of the present invention.
  • the audible commands can be simplified to directing a nurse to administer a medication in a particular package, without regard to the medical name of medication.
  • any responder who can start an intravenous (IV) fluid can administer the proper medications as the situation warrants.
  • a further aspect of a preferred embodiment of the present invention is in combination with an automatic external defibrillator (AED).
  • AED automatic external defibrillator
  • Such combination could, for example, be implemented using the software and hardware components of a preferred embodiment of the present invention and the power source of the AED.
  • the use of a preferred embodiment of the present invention with an AED would result in a modification to the method of a preferred embodiment of the present invention as the AED, not the responder, will recognize the individual rhythms before proceeding with the protocols. In other words, the protocols will remain intact except for the steps which request rhythm recognition. It is noted that drug protocols, IV and airway prompts and CPR cycles are not part of the AED.
  • Another aspect of a preferred embodiment of the present invention relates to a safety issue.
  • the responder when the responder is prompted to select one of a choice of drugs, the choices, while appearing on the same screen, are located at a proximate distance apart so as to avoid inadvertently selecting the wrong choice.
  • confirming prompts may be provided to confirm the choice of the responder. Such confirmation can also be made by using a bar code or similar reader to read bar codes from medicine packaging to confirm steps that have been taken.
  • a list of the actions taken are recorded within the memory portions of the hardware, and further are displayed on the video display for quick reference during the ACLS process.
  • an option can be provided to the user, via the video display or via a separate switch or key stroke, to return to a previous display to review actions taken or the choices that were available.
  • the actions stored in memory can be printed at a printer concurrently as the events are occurring or at a later time. Such actions can be correlated to the actual time such events occurred, such time being a universal worldwide time (UTC) or the local time.
  • UTC universal worldwide time
  • the apparatus will allow the responder to note such mistake, and any actions taken in response thereto, via a keyboard.
  • the apparatus of a preferred embodiment of the present invention will accept an input from the responder of the pronouncement, whereupon the apparatus will provide a prompt to be sure this is the desired action.
  • a preferred embodiment of the present invention will be adapted to receive input from the responder concerning the age, weight and/or height of the patient.
  • the apparatus will be adapted to tailor the correct dosages for the medications and level of voltage shocks to be applied.
  • the video display and audible prompt may provide: "If newborn go to step x, infant go to step y, child go to step z".
  • a look-up table loaded in the memory computer hardware would be have values representing dosage data for newborns, toddlers, small children and children.
  • the same concept is extended to, for example, IV and endotracheal tube sizes. This would advantageously overcome the need to make such calculations during the ACLS procedure.
  • Figures IA- ITTT provide a detailed flow chart of the method that can be implemented in a first embodiment of the apparatus of the present invention, which is used to facilitate resuscitation of adults.
  • the method can modified as described herein so as to facilitate the resuscitation of children.
  • all text in quotations are commands or prompts communicated by the apparatus of the first embodiment of the present invention to the responder, either audibly, visually or both via a sound transducer, touch screen, video display, and the like.
  • a plurality of timers are used in the first embodiment of the present invention, which are used to determine when certain actions are to be taken.
  • the first embodiment of the present invention preferably utilizes six (6) timers (hereinafter referred to as clocks) as follows:
  • CPR clock B This clock is not visible to the responders (and hence is referred to as "internal") and is on a two minute cycle denoting the length of an individual CPR session.
  • ACLS guidelines are very specific about the importance of chest compressions over medications.
  • Vasopressor clock C This is also an internal clock which tracks the timing of this class of medications (Epinephrine or Vasopressin). It cycles every three minutes.
  • Antiarrythmic clock D This internal clock cycles every three minutes and tracks the timing of Epinephrine or Amiodarone.
  • Atropine clock E This internal clock cycles every three minutes and tracks the timing of atropine.
  • the first embodiment of the apparatus of the present invention includes an audible metronomic cadence.
  • Current ACLS protocols emphasize the need for better, faster and uninterrupted CPR.
  • the new rate for chest compressions is 100/min.
  • the audible metronic cadence audibly sets the pace for this rate. Referring now to Figure IA, an initial choice between adult and child is prompted.
  • the apparatus begins at step 1. If child is chosen, the apparatus performs the steps for the resuscitation of a child, which are steps modified, as described below, from the adult version. The steps are taken automatically by the apparatus (based on the algorithm) following the responses and/or inputs from a user (or sensor) in response to the prompts of, and communications from, the apparatus.
  • step 1 external clock A is started.
  • the apparatus communicates: "Attach monitor and defibrillator” and "Check for a pulse”. If a pulse is present, go to step 55. If a pulse is not present, then choose: Ventricular Tachycardia/Ventricular Fibrillation Algorithm (referred to as "V Tach or V Fib” or VT/VF) (go to step 2), Asystole Algorithm (go to step 18) or Pulseless Electrical Activity Algorithm (PEA) (go to step 36).
  • V Tach or V Fib or VT/VF
  • PDA Pulseless Electrical Activity Algorithm
  • step 2 the apparatus communicates: "Defibrillate at 200 joules” and “All Clear” (three times) and "Begin CPR at 100 compressions per minute”. Then the metronomic cadence commences at 100/min. Clock B is set for 2 minutes and then started. The apparatus then communicates: “Is IV access established?” If the user answers yes, then step 3 commences. If no, then the question is asked every 3 minutes until answered yes. The apparatus then communicates: "Is airway device in place and confirmed?" If no, the question can be asked every 5 minutes until an affirmative response is obtained. Further, the prompt could remain on the touch screen until the IV and/or an airway is established.
  • step 3 (VT/VF) as seen in Figure ID
  • clock B reaches 2 minutes and the apparatus communicates: "Stop CPR/Check rhythm”.
  • VT/VF continuously presented: Asystole (go to step 18(b)), PEA (go to step 36(b)) and Pulse returned (go to step 55).
  • the apparatus communicates: "Defibrillate at 300 joules” and “All Clear” (three times) and "Continue CPR at 100 compressions per minute”.
  • the metronomic cadence commences at 100 beats per minute.
  • Clock B is set at 2 minutes and restarted. At this point, if the PV is established, the apparatus continues to step 4.
  • the apparatus continues to prompt until it is established. Meanwhile, if the responder indicates an FV is not established, but an oral airway is in place, the apparatus commences to step 5(a). If oral airway is not in place, the apparatus continues to prompt until an oral airway is in place. The apparatus may indicate that if neither IV nor oral airway is established no medications can be given.
  • step 4 (with IV access) (VT/VF) as seen in Figure IE, the apparatus communicates medicine, dosage and method of administration: Epinephrine 1 mg IV or Vasopressin 40 units IV. Clock C is set for 3 minutes. The apparatus can be made to indicate that Vasopressin can only be given once. Hence, if it is given at this juncture it is not an option in the next step. However, if it is not given at this step, it may be offered as an option one more time. The foregoing applies to step 4(a) as well.
  • step 4(a) without IV access, but with airway device confirmed, the apparatus will communicate: Epinephrine 2.5 mg ET in 5 ml water or NS or Vasopressin 40 units ET in 5 ml water or NS. The apparatus will then communicate: "Stop CPR and give five assisted ventilations”. Clock C is then set for 3 minutes.
  • step 5 the apparatus communicates: "Continue CPR at 100 compressions per minute” and the apparatus will provide a metronomic cadence at 100 beats per minute.
  • the apparatus communicates: "Stop CPR / Check rhythm”. Based on the rhythm, four options are offered for user acceptance: VT/VF (continue below), Asystole (go to step 19(b)), PEA (go to step 38(b)) and Pulse returned (go to step 55). If the first option is chosen, the apparatus communicates: "Defibrillate at 360 joules” and “All Clear” (three times) and "Continue CPR at 100 compressions per minute”. The metronomic cadence commences at 100 beats per minute. Clock B is set at 2 minutes and restarted.
  • step 6 (with IV access) (VT/VF) as seen in Figure IG, the apparatus communicates medicine, dosage and method of administration: Amiodarone 300 mg IV or Lidocaine 1-1.5 mg / kg IV. Clock D is set for 3 minutes.
  • the apparatus will communicate: Lidocaine 2-3 mg / kg ET in 5 ml water or NS. The apparatus will then communicate: "Stop CPR and give five assisted ventilations”. Clock D is then set for 3 minutes.
  • the apparatus can note that Amiodarone can not be given through an airway device, thus it is not provided as an option. Once it is indicated that an IV is established, the apparatus will no longer communicate a need to perform step 10(a) during the remainder of the protocols.
  • step 7 (VT/VF) as seen in Figure IH, clock B reaches 2 minutes and the apparatus communicates: "Stop CPR / Check rhythm”.
  • Four options are then presented: VT/VF (continue below), Asystole (go to step 18(b)), PEA (go to step 36(b)) and Pulse returned (go to step 55). If the first option is chosen, the apparatus communicates:
  • step 8 with IV access
  • the apparatus communicates medicine, dosage and method of administration: Epinephrine 1 mg IV or Vasopressin 40 units IV.
  • Clock C is set for 3 minutes.
  • the apparatus can be made to indicate that Vasopressin can only be given once. However, if it is not given at this step, it may not be offered as an option going forward. The foregoing applies to step 8(a) as well.
  • step 8(a) without IV access, but with airway device confirmed, the apparatus will communicate: Epinephrine 2.5 mg ET in 5 ml water or NS or Vasopressin 40 units ET in 5 ml water or NS.
  • the apparatus will then communicate: "Stop CPR and give five assisted ventilations”.
  • Clock C is then set for 3 minutes.
  • step 9 clock B reaches 2 minutes and the apparatus communicates: "Stop CPR / Check rhythm”.
  • Four options are then presented: VT/VF (continue below), Asystole (go to step 19(b)), PEA (go to step 38(b)) and Pulse returned (go to step 55).
  • the apparatus communicates: "Defibrillate at 360 joules” and “All Clear” (three times) and "Continue CPR at 100 compressions per minute”.
  • the metronomic cadence commences at 100 beats per minute.
  • Clock B is set at 2 minutes and restarted.
  • step 10 (with IV access) (VT/VF) as seen in Figure IK, the apparatus communicates medicine, dosage and method of administration: Amiodarone 150 mg IV or Lidocaine 1-1.5 mg / kg IV. Clock D is set for 3 minutes.
  • step 10(a) without IV access, but with airway device confirmed, the apparatus will communicate: Lidocaine 2-3 mg / kg ET in 5 ml water or NS. The apparatus will then communicate:
  • step 11 VT/VF
  • clock B reaches 2 minutes and the apparatus communicates: "Stop CPR / Check rhythm”.
  • VT/VF discontinue below
  • Asystole go to step 18(b)
  • PEA go to step 36(b)
  • Pulse returned go to step 55.
  • the apparatus communicates: "Defibrillate at 360 joules” and “All Clear” (three times) and "Continue CPR at 100 compressions per minute”.
  • the metronomic cadence commences at 100 beats per minute.
  • Clock B is set at 2 minutes and restarted.
  • step 12 (with F/ access) (VT/VF) as seen in Figure IM, the apparatus communicates medicine, dosage and method of administration: Epinephrine 1 mg IV. Clock C is set for 3 minutes.
  • the apparatus will communicate: Epinephrine 2.5 mg ET in 5 ml water or NS. The apparatus will then communicate: "Stop CPR and give five assisted ventilations”. Clock C is then set for 3 minutes.
  • step 13 clock B reaches 2 minutes and the apparatus communicates: "Stop CPR / Check rhythm”.
  • Four options are then presented: VT/VF (continue below), Asystole (go to step 19(b)), PEA (go to step 38(b)) and Pulse returned (go to step 55).
  • the apparatus communicates: "Defibrillate at 360 joules” and “All Clear” (three times) and "Continue CPR at 100 compressions per minute”.
  • the metronomic cadence commences at 100 beats per minute.
  • Clock B is set at 2 minutes and restarted.
  • step 14 the apparatus communicates: "Has the patient received the maximum dose of 3 mg / kg of Lidocaine?" If the response is no, then the apparatus communicates Lidocaine 1-1.5 mg / kg IV and the clock is not set for this drug. Alternatively, the apparatus continues to step 14(a). If the response is yes, then the apparatus continues to step 15. In step 14(a), without IV access, but with airway device confirmed, the apparatus communicates: Lidocaine 2-3 mg / kg ET in 5 ml water or NS. The apparatus will then communicate: "Stop CPR and give five assisted ventilations".
  • step 15 the apparatus communicates: "Have you considered the following reversible causes?"
  • the following prompts are then communicated: Hypovolemia, Drug overdose, Hypoxia, Cardiac tamponade, Acidosis, Tension pneumothorax, Hyperkalemia, Pulmonary embolism, Hypokalemia, Coronary thrombosis, Hypothermia.
  • the user is then given the option to save the list for later reference or hide the list.
  • the apparatus may include a prompt button or for this list on the screen at this time so if it needs to be referenced again the user has easy access to it.
  • step 16 VT/VF
  • clock B reaches 2 minutes and the apparatus communicates: "Stop CPR / Check rhythm”.
  • VT/VF continuously presented: Asystole (go to step 18(b)), PEA (go to step 36(b)) and Pulse returned (go to step 55).
  • the apparatus communicates: "Defibrillate at 360 joules” and “All Clear” (three times) and "Continue CPR at 100 compressions per minute”.
  • the metronomic cadence commences at 100 beats per minute.
  • Clock B is set at 2 minutes and restarted.
  • step 17 (with IV access) (VT/VF) as seen in Figure IR, the apparatus communicates medicine, dosage and method of administration: Epinephrine 1 mg IV. Clock C is set for 3 minutes.
  • the apparatus will communicate: Epinephrine 2.5 mg ET in 5 ml water or NS. The apparatus will then communicate: "Stop CPR and give five assisted ventilations”. Clock C is then set for 3 minutes.
  • the apparatus performs a nested loop of steps 16 and 17. There are no new medications until the team is ready to "call the code" and pronounce the patient dead. At that point, the termination sequence stays on screen until step 54.
  • step 18 the apparatus communicates: "Confirm asystole in two leads” and "Begin CPR at 100 compressions per minute”.
  • Clock B is then set for 2 minutes and started.
  • the apparatus then prompts: "Is IV access established?” in accordance with step 3. If so, the apparatus continues to step 19. If not, the prompt is continued and asked again every five minutes until an affirmative response is provided. Meanwhile, the apparatus communicates: "Is airway device in place and confirmed?" The prompt is continued and asked again every five minutes until an affirmative response is provided. Further, the prompt could remain on the touch screen until the IV and/or an airway is established.
  • step 18(a) (Asystole) the apparatus communicates: "Confirm asystole in two leads” and "Begin CPR at 100 compressions per minute”.
  • the metronomic cadence commences at 100 beats per minute.
  • Clock B is set at 2 minutes and restarted. Information about the IV and airway from this step is stored in computer memory.
  • step 19 (with IV access) (Asystole) as seen in Figure IT, the apparatus communicates: "Consider transcutaneous pacing".
  • the apparatus communicates medicine, dosage and method of administration: Epinephrine 1 mg IV or Vasopressin 40 units IV.
  • Clock C is set for 3 minutes.
  • the apparatus can be made to indicate that Vasopressin can only be given once. Hence, if it is given at this juncture it is not an option for the next step. However, if it is not given at this step, it may be offered as an option one more time.
  • step 19(a) without IV access, but with airway device confirmed, the apparatus will communicate: Epinephrine 2.5 mg ET in 5 ml water or NS or Vasopressin 40 units ET in 5 ml water or NS. The apparatus will then communicate: "Stop CPR and give five assisted ventilations”. Clock C is then set for 3 minutes. And the apparatus continues to step 20.
  • step 19(b) (Asystole), as seen in Figure IU, the apparatus communicates: "Confirm asystole in two leads" and "Begin CPR at 100 compressions per minute”. Clock B is then set for 2 minutes and started.
  • step 20 Asystole the apparatus communicates: "Consider transcutaneous pacing”.
  • Clock B reaches 2 minutes and the apparatus communicates: "Stop CPR/Check rhythm”.
  • VT/VF continuously to step 20(b)
  • Asystole continuously to step 20(b)
  • PEA progress to step 38(b)
  • Pulse returned go to step 55.
  • the apparatus communicates: "Continue CPR at 100 compressions per minute”.
  • the metronomic cadence commences at 100 beats per minute.
  • Clock B is set at 2 minutes and restarted.
  • step 20(b) the apparatus communicates: "Defibrillate at 200 joules” and “All Clear” (three times) and "Continue CPR at 100 compressions per minute”.
  • the metronomic cadence commences at 100 beats per minute.
  • Clock B is set at 2 minutes and restarted. The apparatus then continues to step 4.
  • step 21 (with IV access) (Asystole) as seen in Figure IV the apparatus communicates medicine, dosage and method of administration: Atropine 1 mg IV.
  • step 21 (a) without IV access, but with airway device confirmed, the apparatus will communicate: Atropine 2 mg ET in 5 ml water or NS. The apparatus will then communicate: "Stop CPR and give five assisted ventilations”. Clock E is then set for
  • the apparatus can remind the responder that that
  • step 22 the apparatus communicates:
  • Tension pneumothorax, Hyperkalemia, Pulmonary embolism, Hypokalemia, Coronary thrombosis, Hypothermia The user is then given the option to save the list for later reference or hide the list.
  • the apparatus may include a prompt button or for this list on the screen at this time so if it needs to be referenced again the user has easy access to it.
  • step 23 Asystole, as seen in Figure IX clock B reaches 2 minutes and the apparatus communicates: "Stop CPR/Check rhythm". Four options are then presented:
  • VT/VF discontinue to step 20(b)
  • Asystole continue to step 20(b)
  • PEA continue to step 36(b)
  • Pulse returned go to step 55.
  • the apparatus communicates: "Continue CPR at 100 compressions per minute”.
  • the metronomic cadence commences at 100 beats per minute.
  • Clock B is set at 2 minutes and restarted.
  • step 24 (with IV access) (Asystole) as seen in Figure IY, the apparatus communicates medicine, dosage and method of administration: Epinephrine 1 mg IV or Vasopressin 40 units IV.
  • Clock C is set for 3 minutes.
  • the apparatus can be made to indicate that Vasopressin can only be given once. Hence, if it is given at this juncture it is not an option for the next step. However, if it is not given at this step, it may be offered as an option one more time.
  • step 24(a) without IV access, but with airway device confirmed, the apparatus will communicate: Epinephrine 2.5 mg ET in 5 ml water or NS or Vasopressin 40 units ET in 5 ml water or NS. The apparatus will then communicate: "Stop CPR and give five assisted ventilations".
  • Clock C is then set for 3 minutes.
  • step 25 the apparatus communicates: "Stop CPR/Check rhythm”.
  • VT/VF continuously to step 20(b)
  • Asystole continuously to step 38(b)
  • Pulse returned (go to step 55).
  • the apparatus communicates: "Continue CPR at 100 compressions per minute”.
  • the metronomic cadence commences at 100 beats per minute.
  • Clock B is set at 2 minutes and restarted.
  • step 26 (with IV access) (Asystole) as seen in Figure IAA, the apparatus communicates medicine, dosage and method of administration: Atropine 1 mg IV.
  • step 26(a) without IV access, but with airway device confirmed, the apparatus will communicate: Atropine 2 mg ET in 5 ml water or NS. The apparatus will then communicate: "Stop CPR and give five assisted ventilations”. Clock E is then set for 3 minutes. It is flagged internally by the apparatus that this is the second of four total doses of Atropine that can be given. Such fact can also be communicated to the responder as a reminder.
  • step 27 the apparatus communicates: "Have you considered the following reversible causes?"
  • the following prompts are then communicated: Hypovolemia, Drug overdose, Hypoxia, Cardiac tamponade, Acidosis, Tension pneumothorax, Hyperkalemia, Pulmonary embolism, Hypokalemia, Coronary thrombosis, Hypothermia.
  • the user is then given the option to save the list for later reference or hide the list.
  • the apparatus may include a prompt button or for this list on the screen at this time so if it needs to be referenced again the user has easy access to it.
  • step 28 Asystole
  • clock B reaches 2 minutes and the apparatus communicates: "Stop CPR/Check rhythm”.
  • VT/VF continuously to step 20(b)
  • Asystole continuously to step 36(b)
  • Pulse returned go to step 55.
  • the apparatus communicates: "Continue CPR at 100 compressions per minute”.
  • the metronomic cadence commences at 100 beats per minute.
  • Clock B is set at 2 minutes and restarted.
  • step 29 (with IV access) (Asystole) as seen in Figure IDD, the apparatus communicates medicine, dosage and method of administration: Epinephrine 1 mg IV. Clock C is set for 3 minutes.
  • the apparatus will communicate: Epinephrine 2.5 mg ET in 5 ml water or NS. The apparatus will then communicate: "Stop CPR and give five assisted ventilations”. Clock C is then set for 3 minutes. At this point, a termination sequence remains on the video display until step 54.
  • step 30 the apparatus communicates: "Stop CPR/Check rhythm”.
  • VT/VF continuously to step 20(b)
  • Asystole continuously to step 38(b)
  • Pulse returned (go to step 55).
  • the apparatus communicates: "Continue CPR at 100 compressions per minute”.
  • the metronomic cadence commences at 100 beats per minute.
  • Clock B is set at 2 minutes and restarted.
  • step 31 with IV access
  • the apparatus communicates medicine, dosage and method of administration: Atropine 1 mg IV.
  • step 31 (a) without IV access, but with airway device confirmed, the apparatus will communicate: Atropine 2 mg ET in 5 ml water or NS. The apparatus will then communicate: "Stop CPR and give five assisted ventilations”. Clock E is then set for 3 minutes. It is flagged internally by the apparatus that this is the third of four total doses of Atropine that can be given. Such fact can also be communicated to the responder as a reminder.
  • step 32 Asystole
  • clock B reaches 2 minutes and the apparatus communicates: "Stop CPR/Check rhythm".
  • VT/VF continuously to step 20(b)
  • Asystole continuously to step 36(b)
  • Pulse returned go to step 55.
  • the apparatus communicates: "Continue CPR at 100 compressions per minute”.
  • the metronomic cadence commences at 100 beats per minute.
  • Clock B is set at 2 minutes and restarted.
  • step 33 with IV access
  • the apparatus communicates medicine, dosage and method of administration: Epinephrine 1 mg IV.
  • Clock C is set for 3 minutes.
  • step 33(a) without IV access, but with airway device confirmed, the apparatus will communicate: Epinephrine 2.5 mg ET in 5 ml water or NS. The apparatus will then communicate: "Stop CPR and give five assisted ventilations”. Clock C is then set for 3 minutes.
  • step 34 Asystole
  • clock B reaches 2 minutes and the apparatus communicates: "Stop CPR/Check rhythm”.
  • VT/VF continuously to step 20(b)
  • Asystole continuously to step 38(b)
  • Pulse returned go to step 55.
  • the apparatus communicates: "Continue CPR at 100 compressions per minute”.
  • the metronomic cadence commences at 100 beats per minute.
  • Clock B is set at 2 minutes and restarted.
  • step 35 (with IV access) (Asystole) as seen in Figure IJJ, the apparatus communicates medicine, dosage and method of administration: Atropine 1 mg IV.
  • the apparatus will communicate: Atropine 2 mg ET in 5 ml water or NS.
  • the apparatus will then communicate: "Stop CPR and give five assisted ventilations”.
  • Clock E is then set for 3 minutes. It is flagged internally by the apparatus that this is the fourth of four total doses of Atropine that can be given. Such fact can also be communicated to the responder as a reminder.
  • a termination sequence remains on the video display from step 54. Steps 32 and 33 are looped until the responder calls the code or the termination portion of the method is invoked. At this point, there are no further drugs to be administered of actions to be taken.
  • step 36 the apparatus communicates: "Begin CPR at 100 compressions per minute”. Then the metronomic cadence commences at 100 beats per minute. Clock B is set for 2 minutes and then started. The apparatus then communicates: "Is IV access established?" If the user answers yes, then the method returns to step 3. If no, then the question is asked every 5 minutes until answered yes. The apparatus then communicates: "Is airway device in place and confirmed?" If no, the question can be asked every 5 minutes until an affirmative response is obtained. Further, the prompt could remain on the touch screen until the IV and/or an airway is established. If yes, the method continues to step 37.
  • step 36(b) PEA as seen in Figure INN, the apparatus communicates: "Begin CPR at 100 compressions per minute”. Then the metronomic cadence commences at 100 beats per minute. Clock B is set for 2 minutes and then started.
  • step 37 (with IV access) (PEA) as seen in Figure ILL, the apparatus communicates medicine, dosage and method of administration: Epinephrine 1 mg IV or Vasopressin 40 units IV.
  • Clock C is set for 3 minutes.
  • the apparatus can be made to indicate that Vasopressin can only be given once. Hence, if it is given at this juncture it is not an option in the next step. However, if it is not given at this step, it may be offered as an option one more time.
  • step 37(a) without IV access, but with airway device confirmed, the apparatus will communicate: Epinephrine 2.5 mg ET in 5 ml water or NS or Vasopressin 40 units ET in 5 ml water or NS. The apparatus will then communicate: "Stop CPR and give five assisted ventilations".
  • Clock C is then set for 3 minutes.
  • step 38 the apparatus communicates: "Stop CPR / Check rhythm”. Based on the rhythm, four options are offered for user acceptance: VT/VF (go to step 20(b)), Asystole (go to step 19(b)), PEA (continue below) and Pulse returned (go to step 55).
  • the apparatus communicates: "Continue CPR at 100 compressions per minute”.
  • the metronomic cadence commences at 100 beats per minute.
  • Clock B is set at 2 minutes and restarted.
  • the apparatus communicates: "Is the heart rate less than 60" If the user selects yes, the method continues to step 39. If the user selects no, the method continues to step 40.
  • step 39 (with IV access) (PEA) as seen in Figure INN, the apparatus communicates medicine, dosage and method of administration: Atropine 1 mg IV.
  • the apparatus will communicate: Atropine 2 mg ET in 5 ml water or NS.
  • the apparatus will then communicate: "Stop CPR and give five assisted ventilations”.
  • Clock E is then set for 3 minutes. It is flagged internally by the apparatus that this is the first of four total doses of Atropine that can be given. Such fact can also be communicated to the responder as a reminder.
  • step 40 the apparatus communicates: "Have you considered the following reversible causes?"
  • the following prompts are then communicated: Hypovolemia, Drug overdose, Hypoxia, Cardiac tamponade, Acidosis, Tension pneumothorax, Hyperkalemia, Pulmonary embolism, Hypokalemia, Coronary thrombosis, Hypothermia.
  • the user is then given the option to save the list for later reference or hide the list.
  • the apparatus may include a prompt button or for this list on the screen at this time so if it needs to be referenced again the user has easy access to it.
  • step 41 (PEA) as seen in Figure IPP, clock B reaches 2 minutes and the apparatus communicates: "Stop CPR/Check rhythm".
  • VT/VF continuously VT/VF
  • Asystole continue to step 18(b)
  • PEA continuously VT/VF
  • Pulse returned go to step 55.
  • the apparatus communicates: "Continue CPR at 100 compressions per minute”.
  • the metronomic cadence commences at 100 beats per minute.
  • Clock B is set at 2 minutes and restarted.
  • step 42 (with IV access) (PEA) as seen in Figure IQQ, the apparatus communicates medicine, dosage and method of administration: Epinephrine 1 mg IV or Vasopressin 40 units FV.
  • Clock C is set for 3 minutes.
  • the apparatus can be made to indicate that Vasopressin can only be given once. Hence, if it is given at this juncture it is not an option for the next step. However, if it is not given at this step, it may be offered as an option one more time.
  • step 42(a) without IV access, but with airway device confirmed, the apparatus will communicate: Epinephrine 2.5 mg ET in 5 ml water or NS or Vasopressin 40 units ET in 5 ml water or NS. The apparatus will then communicate: "Stop CPR and give five assisted ventilations”.
  • Clock C is then set for 3 minutes.
  • step 43 (PEA) as seen in Figure IRR, clock B reaches 2 minutes and the apparatus communicates: "Stop CPR/Check rhythm".
  • VT/VF continuously VT/VF
  • Asystole continue to step 19(b)
  • PEA continuously VT/VF
  • Pulse returned go to step 55.
  • the apparatus communicates: "Continue CPR at 100 compressions per minute”.
  • the metronomic cadence commences at 100 beats per minute.
  • Clock B is set at 2 minutes and restarted.
  • the apparatus communicates: "Is the heart rate less than 60" If the user selects yes, the method continues to step 44. If the user selects no, the method continues to step 45.
  • step 44 (with FV access) (PEA) as seen in Figure ISS, the apparatus communicates medicine, dosage and method of administration: Atropine 1 mg IV.
  • the apparatus will communicate: Atropine 2 mg ET in 5 ml water or NS.
  • the apparatus will then communicate: "Stop CPR and give five assisted ventilations”.
  • Clock E is then set for 3 minutes. It is flagged internally by the apparatus that this is the second of four total doses of Atropine that can be given. Such fact can also be communicated to the responder as a reminder.
  • step 45 the apparatus communicates: "Have you considered the following reversible causes?"
  • the following prompts are then communicated: Hypovolemia, Drug overdose, Hypoxia, Cardiac tamponade, Acidosis, Tension pneumothorax, Hyperkalemia, Pulmonary embolism, Hypokalemia, Coronary thrombosis, Hypothermia.
  • the user is then given the option to save the list for later reference or hide the list.
  • the apparatus may include a prompt button or for this list on the screen at this time so if it needs to be referenced again the user has easy access to it.
  • step 46 (PEA) as seen in Figure IUU, clock B reaches 2 minutes and the apparatus communicates: "Stop CPR/Check rhythm".
  • VT/VF continuously VT/VF
  • Asystole continue to step 18(b)
  • PEA continuously VT/VF
  • Pulse returned go to step 55.
  • the apparatus communicates: "Continue CPR at 100 compressions per minute”.
  • the metronomic cadence commences at 100 beats per minute.
  • Clock B is set at 2 minutes and restarted.
  • step 47 with IV access
  • the apparatus communicates medicine, dosage and method of administration: Epinephrine 1 mg IV. Clock C is set for 3 minutes.
  • the apparatus will communicate: Epinephrine 2.5 mg ET in 5 ml water or NS. The apparatus will then communicate: "Stop CPR and give five assisted ventilations”. Clock C is then set for 3 minutes. At this point, a termination sequence remains on the video display until step 54.
  • step 48 PEA as seen in Figure IWW, the apparatus communicates: "Stop
  • CPR/Check rhythm Four options are then presented: VT/VF (continue to step 20(b)), Asystole (go to step 19(b)), PEA (continue below) and Pulse returned (go to step 55).
  • the apparatus communicates: "Continue CPR at 100 compressions per minute”.
  • the metronomic cadence commences at 100 beats per minute.
  • Clock B is set at 2 minutes and restarted.
  • the apparatus communicates: "Is the heart rate less than 60" If the user selects yes, the method continues to step 49. If the user selects no, the method continues to step 50.
  • step 49 (with IV access) (PEA) as seen in Figure IXX, the apparatus communicates medicine, dosage and method of administration: Atropine 1 mg IV.
  • the apparatus will communicate: Atropine 2 mg ET in 5 ml water or NS.
  • the apparatus will then communicate: "Stop CPR and give five assisted ventilations”.
  • Clock E is then set for 3 minutes. It is flagged internally by the apparatus that this is the third of four total doses of Atropine that can be given. Such fact can also be communicated to the responder as a reminder.
  • step 50 (PEA) as seen in Figure IYY, clock B reaches 2 minutes and the apparatus communicates: "Stop CPR/Check rhythm".
  • VT/VF continuously VT/VF
  • Asystole continue to step 18(b)
  • PEA continuously VT/VF
  • Pulse returned go to step 55.
  • the apparatus communicates: "Continue CPR at 100 compressions per minute”.
  • the metronomic cadence commences at 100 beats per minute.
  • Clock B is set at 2 minutes and restarted.
  • step 51 with IV access
  • the apparatus communicates medicine, dosage and method of administration: Epinephrine 1 mg IV.
  • Clock C is set for 3 minutes.
  • the apparatus will communicate: Epinephrine 2.5 mg ET in 5 ml water or NS.
  • the apparatus will then communicate: "Stop CPR and give five assisted ventilations”.
  • Clock C is then set for 3 minutes.
  • step 52 (PEA) as seen in Figure IAAA, clock B reaches 2 minutes and the apparatus communicates: "Stop CPR/Check rhythm". Four options are then presented:
  • VT/VF discontinue to step 20(b)
  • Asystole continue to step 19(b)
  • PEA continue to step 19(b)
  • Pulse returned (go to step 55).
  • the apparatus communicates: "Continue CPR at 100 compressions per minute”.
  • the metronomic cadence commences at 100 beats per minute.
  • Clock B is set at 2 minutes and restarted.
  • the apparatus communicates: "Is the heart rate less than 60" If the user selects yes, the method continues to step 53. If the user selects no, the method continues to step 54.
  • step 53 (with IV access) (PEA) as seen in Figure IBBB, the apparatus communicates medicine, dosage and method of administration: Atropine 1 mg IV.
  • step 53(a) without IV access, but with airway device confirmed, the apparatus will communicate: Atropine 2 mg ET in 5 ml water or NS. The apparatus will then communicate: "Stop CPR and give five assisted ventilations”. Clock E is then set for
  • Steps 50 and 51 are looped until the responder calls the code or the termination portion of the method is invoked. At this point, there are no further drugs to be administered of actions to be taken.
  • step 54 the termination sequence is invoked.
  • the apparatus communicates: "Are you sure you want to end ACLS activities?" If yes, then the apparatus communicates: "Confirm you want to end ACLS activities?" If no, the loop continues.
  • the user is given an option to print a summary of events with the timing of drugs given relative to the external clocks and the internal elapsed time clock.
  • a sheet of paper having an adhesive back that can be inserted into the apparatus, printed on and then ejected from the apparatus.
  • step 55 the apparatus communicates: "Check blood pressure and heart rate”. Three options are then presented: Is the heart rate less than 60? (go to step 56); Is the heart rate 60 to 120? (go to step 68) Is the heart rate greater than 120? (go to step 61).
  • step 56 Braincardia
  • the apparatus communicates: "Is the patient symptomatic or unstable?" Two options are presented for selection. If no, then continue below. If yes, then (go to step 58). The apparatus communicates: "Obtain 12 lead EKG”. Then two options are presented for selection. Type II or III AV block? If no, then continue below.
  • step 57 The apparatus communicates: "Place transcutaneous pacer pads on patient, monitor and observe,” and “Give oxygen”. An option is then presented: If patient becomes unstable or symptomatic press here. If the option is selected, the method goes to step 58.
  • step 57 the apparatus communicates "Place transcutaneous pacer pads on patient, monitor and observe,” and “Give oxygen” and "Prepare for transvenous pacemaker". The responder may then be reminded and prompted: If symptoms develop, use transcutaneous pacer until transvenous pacemaker placed and Immediate expert consultation.
  • step 58 (Bradycardia) as seen in Figure IGGG, the apparatus communicates medicine, dosage and method of administration: Atropine 0.5 mg IV.
  • Clock E is set for 3 minutes.
  • the apparatus communicates: "Place transcutaneous pacer pads on patient” and “Give oxygen” and "If heart rate remains low consider:” and the following are displayed on the video display: Atropine 0.5 mg every 3-5 minutes up to six doses; Epinephrine infusion 2 to 10 mcg/min; Dopamine infusion 2 to 10 mcg/kg/min; and Look for underlying causes.
  • step 59 Braincardia
  • the apparatus communicates: "Is the heart rate less than 60" or "Is the patient symptomatic or unstable?" Two options are presented for selection. If no, then continue below. If yes is selected (go to step 60). The apparatus will then prompt: If patient is now stable with no serious signs or symptoms - monitor and observe.
  • step 60 the apparatus communicates "Use transcutaneous pacer".
  • the apparatus communicates medicine, dosage and method of administration: Atropine 0.5 mg IV.
  • Clock E is set for 3 minutes.
  • the apparatus communicates: "If heart rate remains low consider:” and the following are displayed on the video display: Immediate Expert consultation; Atropine 0.5 mg every 3-5 minutes up to six doses; Epinephrine infusion 2 to 10 mcg/min; Dopamine infusion 2 to 10 mcg/kg/min; and Look for underlying causes.
  • step 61 Braincardia/unstable as seen in Figure IJJJ
  • the apparatus communicates: "Is the patient stable?" Two options are presented for selection. Unstable (continue below) and stable (go to step 63). The apparatus communicates: “Immediate synchronized cardioversion 100 joules”. The apparatus communicates: “Is the patient stable?" If unstable, continue below. If stable is selected, go to step 63. The apparatus communicates: "Immediate synchronized cardioversion 200 joules”.
  • step 62 Braincardia/unstable as seen in Figure IKKK, the apparatus communicates: "Is the patient stable?" Two options are presented for selection. Unstable
  • the apparatus communicates: "Immediate synchronized cardioversion 300 joules”.
  • the apparatus communicates: "Is the patient stable?" If unstable, continue below. If stable is selected, go to step 63.
  • the apparatus communicates: "Immediate synchronized cardioversion 360 joules”. The method then goes to step 55.
  • step 63 (Tachycardia / stable) as seen in Figure ILLL, the apparatus communicates: "Give oxygen” and “Establish IV access” and “Immediate expert consultation” and "Obtain 12 lead EKG”.
  • QRS narrow ⁇ .12 sec
  • QRS wide >.12 sec
  • Regular rhythm ⁇ .12 sec
  • Irregular rhythm ⁇ .12 sec
  • step 64 (Tachycardia / stable / narrow / regular) as seen in Figure IMMM, the apparatus communicates: "Consider treating for SVT" and the following reminders are provided: Expert consultation; Vagal maneuvers; Adenosine rapid IV push; Monitor; Oxygen. The apparatus then continues to step 70.
  • step 65 (Tachycardia / stable / narrow / irregular) as seen in Figure INNN, the apparatus communicates: "Consider treating for A-fib / flutter" and the following reminders are provided: Expert consultation; Consider rate control with diltiazem IV; Monitor; Oxygen. The apparatus then continues to step 70.
  • step 66 (Tachycardia / stable / narrow / regular) as seen in Figure 1OOO, the apparatus provides two options: Regular rhythm (continue below) and Irregular rhythm (go to step 67).
  • the apparatus then communicates: "Consider Stable Ventricular tachycardia" and the following reminders are provided: Amiodarone 150 mg FV over 10 minutes; Be prepared for synchronized cardioversion if patient becomes unstable; Expert consultation; Monitor; Oxygen.
  • the apparatus then continues to step 70.
  • step 67 (Tachycardia / stable / wide / irregular) as seen in Figure IPPP, the apparatus provides the following reminders: Expert consultation; May consider
  • step 68 normal heart rate
  • the apparatus communicates: "Give oxygen” and "Establish IV access”.
  • the apparatus provides the following reminders: Immediate expert consultation; Obtain 12 lead EKG; and Monitor vital signs and symptoms.
  • the apparatus then continues to step 70.
  • step 70 post-resuscitation
  • the apparatus provides the following reminders: Consult expert; Oxygen; Monitor vital signs and symptoms; Check D-stick; Obtain 12 lead EKG; Send appropriate labs; Consider vasoactive medication infusions.
  • the steps taken by the apparatus if the patient selection is a child, are similar to those taken if the patient selected is an adult, with such modifications are necessary due to the physiological differences between adults and children. Such modifications are as follows.
  • external clock A is started.
  • the apparatus communicates: "Check for a pulse” and "Attach monitor and defibrillator". If a pulse is present, go to pediatric step 31. If a pulse is not present, then "Begin CPR at 100 compressions per minute”.
  • the metronomic cadence commences at 100/min.
  • the apparatus communicates: "Check rhythm”. The two choices are offered: VT/VF (go to pediatric step 2), Asystole/PEA Algorithm (go to pediatric step 18).
  • the apparatus communicates: "Defibrillate at 2 joules per kilogram” and “All Clear” (three times) and "Continue CPR at 100 compressions per minute”.
  • the metronomic cadence commences at 100/min. Clock B is set for 2 minutes and then started.
  • the apparatus then communicates: "Is IV or IO access established?” If the user answers yes, then pediatric step 3 commences. If no, then the question is asked every 3 minutes until answered yes.
  • the apparatus then communicates: "Is airway device in place and confirmed?” If no, the question can be asked every 5 minutes until an affirmative response is obtained. Further, the prompt could remain on the touch screen until the IV and/or an airway is established.
  • VT/VF clock B reaches 2 minutes and the apparatus communicates: "Stop CPR/Check rhythm". Three options are then presented: VT/VF (continue below), Asystole (go to pediatric step 18), Organized Rhythm (go to pediatric step 28(b)). If the first option is chosen, the apparatus communicates: "Defibrillate at 4 joules per kilogram” and “All Clear” (three times) and "Continue CPR at 100 compressions per minute”. The metronomic cadence commences at 100 beats per minute. Clock B is set at 2 minutes and restarted. At this point, if IV/IO is established, the apparatus continues to pediatric step 4. If the IV/IO are not established, the apparatus continues to prompt until it is established.
  • the apparatus commences to pediatric step 5 (a). If an oral airway is not in place, the apparatus continues to prompt until an oral airway is in place. The apparatus may indicate that if neither device is established no medications can be given.
  • step 4 (with IV or IO access) (VT/VF) the apparatus communicates medicine, dosage and method of administration: Epinephrine 0.01 mg IV / IO (1:10,000; 0.1 ml / kg). Clock C is set for 3 minutes.
  • the apparatus will communicate: Epinephrine 0.1 mg / kg ET in 5 ml NS (1:1,000; 0.1 ml / kg). The apparatus will then communicate: "Stop CPR and give five assisted ventilations”. Clock C is then set for 3 minutes.
  • VTATF In pediatric step 5 (VTATF) the apparatus communicates: "Continue CPR at 100 compressions per minute” and the apparatus will provide a metronomic cadence at 100 beats per minute. Once clock B reaches 2 minutes, the apparatus communicates: "Stop CPR / Check rhythm”. Three options are then presented: VTA 7 F (continue below), Asystole (go to pediatric step 18), Organized Rhythm (go to pediatric step 28(b)). If the first option is chosen, the apparatus communicates: "Defibrillate at 4 joules per kilogram” and “All Clear” (three times) and "Continue CPR at 100 compressions per minute". The metronomic cadence commences at 100 beats per minute. Clock B is set at 2 minutes and restarted.
  • step 6 (with IV / IO access) (VTA 7 F) the apparatus communicates medicine, dosage and method of administration: Amiodarone 5 mg / kg IV / IO or Lidocaine 1 mg / kg PV / IO. Clock D is set for 3 minutes.
  • the apparatus will communicate: Lidocaine 2-3 mg / kg ET in 5 ml water or NS. The apparatus will then communicate: "Stop CPR and give five assisted ventilations”. Clock D is then set for 3 minutes.
  • the apparatus can note that Amiodarone can not be given through an airway device, thus it is not provided as an option.
  • step 8 (with IV / IO access) (VT/VF) the apparatus communicates medicine, dosage and method of administration: Epinephrine 0.01 mg IV / IO (1:10,000; 0.1 ml / kg). Clock C is set for 3 minutes.
  • the apparatus will communicate: Epinephrine 0.1 mg / kg ET in 5 ml NS (1:1,000; 0.1 ml / kg). The apparatus will then communicate: "Stop CPR and give five assisted ventilations”. Clock C is then set for 3 minutes.
  • clock B reaches 2 minutes and the apparatus communicates: "Stop CPR / Check rhythm".
  • VT/VF discontinue below
  • Asystole go to pediatric step 18
  • Organized Rhythm go to pediatric step 28(b)
  • the apparatus communicates: "Defibrillate at 4 joules per kilogram” and “All Clear” (three times) and "Continue CPR at 100 compressions per minute”.
  • the metronomic cadence commences at 100 beats per minute.
  • Clock B is set at 2 minutes and restarted.
  • VT/VF discontinue below
  • Asystole go to pediatric step 18
  • Organized Rhythm go to pediatric step 28(b)
  • the apparatus communicates: "Defibrillate at 4 joules per kilogram” and “All Clear” (three times) and "Continue CPR at 100 compressions per minute”.
  • the metronomic cadence commences at 100 beats per minute.
  • Clock B is set at 2 minutes and restarted.
  • VT/VF discontinue below
  • Asystole go to pediatric step 18
  • Organized Rhythm go to pediatric step 28(c)
  • the apparatus communicates: "Defibrillate at 4 joules per kilogram” and “All Clear” (three times) and "Continue CPR at 100 compressions per minute”.
  • the metronomic cadence commences at 100 beats per minute.
  • Clock B is set at 2 minutes and restarted.
  • the apparatus communicates: "Has the patient received the maximum dose of 100 mg of Lidocaine?" If the response is no, then the apparatus communicates, in pediatric step 14(a): Lidocaine 1 mg / kg IV / IO and the clock is no longer set. Alternatively, the apparatus continues to pediatric step 14(b). If the response is yes, then the apparatus continues to pediatric step 15. In pediatric step 14(b), without IV access, but with airway device confirmed, the apparatus communicates: Lidocaine 2-3 mg / kg ET in 5 ml water or NS. The apparatus will then communicate: "Stop CPR and give five assisted ventilations". The clock is no longer set.
  • step 15 the apparatus communicates: "Have you considered the following reversible causes?"
  • the following prompts are then communicated: Hypovolemia, Drug overdose, Hypoxia, Cardiac tamponade, Acidosis, Tension pneumothorax, Hyperkalemia, Pulmonary embolism, Hypokalemia, Coronary thrombosis, Hypothermia.
  • the user is then given the option to save the list for later reference or hide the list.
  • the apparatus may include a prompt button or for this list on the screen at this time so if it needs to be referenced again the user has easy access to it.
  • VT/VF clock B reaches 2 minutes and the apparatus communicates: "Stop CPR / Check rhythm”. Three options are then presented: VT/VF (continue below), Asystole (go to pediatric step 18), Organized Rhythm (go to pediatric step 28(c)). If the first option is chosen, the apparatus communicates: "Defibrillate at 4 joules per kilogram” and “All Clear” (three times) and "Continue CPR at 100 compressions per minute”. The metronomic cadence commences at 100 beats per minute. Clock B is set at 2 minutes and restarted.
  • step 17 (with FV / IO access) (VT/VF) the apparatus communicates medicine, dosage and method of administration: Epinephrine 0.01 mg FV / IO (1:10,000; 0.1 ml / kg). Clock C is set for 3 minutes.
  • the apparatus will communicate: Epinephrine 0.1 mg / kg ET in 5 ml NS (1:1,000; 0.1 ml / kg). The apparatus will then communicate: "Stop CPR and give five assisted ventilations”. Clock C is then set for 3 minutes. At this point in the method, the apparatus performs a nested loop of pediatric steps 16 and 17.
  • Clock B is then set for 2 minutes and started.
  • the apparatus then prompts: "Is FV / IO access established?” in accordance with pediatric step 3. If not, the prompt is continued and asked again every five minutes until an affirmative response is provided. Meanwhile, the apparatus communicates: "Is airway device in place and confirmed?" The prompt is continued and asked again every five minutes until an affirmative response is provided. The prompt could remain on the touch screen until the IV / IO and/or an airway is established.
  • step 19 (with IV / IO access) (Asystole / PEA) the apparatus communicates medicine, dosage and method of administration: Epinephrine 0.01 mg IV / IO (1:10,000; 0.1 ml / kg). Clock C is set for 3 minutes.
  • the apparatus will communicate: Epinephrine 0.1 mg / kg ET in 5 ml NS (1:1,000; 0.1 ml / kg). The apparatus will then communicate: "Stop CPR and give five assisted ventilations”. Clock C is then set for 3 minutes.
  • step 20 In pediatric step 20 (Asystole / PEA) clock B reaches 2 minutes and the apparatus communicates: "Stop CPR/Check rhythm". Three options are then presented: VT/VF (go to pediatric step 2), Asystole (continue below), Organized Rhythm (go to pediatric step 28(b)). The apparatus communicates: "Continue CPR at 100 compressions per minute”. The metronomic cadence commences at 100 beats per minute. Clock B is set at 2 minutes and restarted.
  • step 21 (with IV / IO access) (Asystole / PEA) the apparatus communicates medicine, dosage and method of administration: Epinephrine 0.01 mg IV / IO (1:10,000; 0.1 ml / kg). Clock C is set for 3 minutes.
  • the apparatus will communicate: Epinephrine 0.1 mg / kg ET in 5 ml NS (1:1,000; 0.1 ml / kg). The apparatus will then communicate: "Stop CPR and give five assisted ventilations”. Clock C is then set for 3 minutes.
  • step 22 the apparatus communicates: "Have you considered the following reversible causes?" The following prompts are then communicated: Hypovolemia, Drug overdose, Hypoxia, Cardiac tamponade, Acidosis, Tension pneumothorax, Hyperkalemia, Pulmonary embolism, Hypokalemia, Coronary thrombosis, Hypothermia. The user is then given the option to save the list for later reference or hide the list.
  • the apparatus may include a prompt button or for this list on the screen at this time so if it needs to be referenced again the user has easy access to it.
  • step 23 In pediatric step 23 (Asystole / PEA) clock B reaches 2 minutes and the apparatus communicates: "Stop CPR/Check rhythm". Three options are then presented: VT/VF (go to pediatric step 2), Asystole (continue below), Organized Rhythm (go to pediatric step 28(b)). The apparatus communicates: "Continue CPR at 100 compressions per minute”. The metronomic cadence commences at 100 beats per minute. Clock B is set at 2 minutes and restarted.
  • step 24 (with IV / IO access) (Asystole / PEA) the apparatus communicates medicine, dosage and method of administration: Epinephrine 0.01 mg IV /
  • the apparatus will communicate: Epinephrine 0.1 mg / kg ET in 5 ml NS (1 :1,000; 0.1 ml / kg). The apparatus will then communicate: "Stop CPR and give five assisted ventilations”. Clock C is then set for 3 minutes.
  • step 26 the apparatus communicates: "Have you considered the following reversible causes?" The following prompts are then communicated: Hypovolemia, Drug overdose, Hypoxia, Cardiac tamponade, Acidosis, Tension pneumothorax, Hyperkalemia, Pulmonary embolism, Hypokalemia, Coronary thrombosis, Hypothermia. The user is then given the option to save the list for later reference or hide the list.
  • the apparatus communicates medicine, dosage and method of administration: Epinephrine 0.01 mg IV / IO (1:10,000; 0.1 ml / kg). Clock C is set for 3 minutes.
  • the apparatus will communicate: Epinephrine 0.1 mg / kg ET in 5 ml NS (1:1,000; 0.1 ml / kg). The apparatus will then communicate: "Stop CPR and give five assisted ventilations”. Clock C is then set for 3 minutes.
  • the apparatus performs a nested loop of pediatric steps 25 to 27.
  • Pediatric step 28(c) creates the loop. There are no new medications until the team is ready to "call the code" and pronounce the patient dead. At that point, the termination sequence stays on screen until pediatric step 54.
  • Pediatric steps 28(a)-(c) comprise pediatric step 28 (Organized Rhythm).
  • the apparatus communicates "Check Pulse.” If a pulse is present, then the apparatus goes to pediatric step 29. If there is no pulse, the apparatus goes to pediatric step 21.
  • the apparatus communicates "Check Pulse.” If a pulse is present, then the apparatus goes to pediatric step 29. If there is no pulse, the apparatus goes to pediatric step 24.
  • the apparatus communicates "Check Pulse.” If a pulse is present, then the apparatus goes to pediatric step 29. If there is no pulse, the apparatus goes to pediatric step 27.
  • step 29 post-resuscitative care / decompensated
  • the apparatus communicates: "Check vital signs” and "Consider a fluid bolus” (10-20 mL/ kg of NS or RL).
  • the apparatus then prompts: Hypotensive or Decompensated (continue below) or Normotensive or compensated (go to pediatric step 30).
  • the apparatus then prompts: Consider further fluid boluses; Consider: Oxygen, labs, CXR, pain control, NG-tube, secure IV lines, pulse oximeter and monitor; Epinephrine drip at 0.1 to 1 meg / kg / min; and / or Dopamine drip 2 to 20 meg / kg / min; and / or Norepinephrine drip 0.1 to 2 meg / kg / min.
  • the apparatus prompts: Consider further fluid boluses; Consider: Oxygen, labs, CXR, pain control, NG-tube, secure IV lines, pulse oximeter and monitor; Dobutamine drip at 2 to 20 meg / kg / min; and / or Dopamine drip 2 to 20 meg / kg / min and / or Epinephrine drip 0.05 to 0.3 meg / kg / min and / or Milrinone drip: Load with 50 to 75 meg / kg.
  • the apparatus communicates: "Is there poor perfusion despite proper ventilation?" If yes, go to pediatric step 34(a), if not, the apparatus communicates: "Monitor, ventilate and observe”. In pediatric step 34(a) (unstable bradycardia) the apparatus communicates: "Continue CPR at 100 compressions per minute”. The metronomic cadence commences at 100 beats per minute. Clock B is set at 2 minutes and restarted.
  • the apparatus communicates medicine, dosage and method of administration: Epinephrine 0.01 mg IV / IO (1:10,000; 0.1 ml / kg). Clock C is set for 3 minutes.
  • the apparatus communicates: Epinephrine 0.1 mg / kg ET in 5 ml NS (1:1,000; 0.1 ml / kg). The apparatus will then communicate: "Stop CPR and give five assisted ventilations”. Clock C is then set for 3 minutes. The apparatus communicates: "Check D-stick".
  • step 36 Unstable bradycardia
  • the apparatus communicates: "Have you considered the following reversible causes?" The following prompts are then communicated: Hypovolemia, Drug overdose, Hypoxia, Cardiac tamponade, Acidosis, Tension pneumothorax, Hyperkalemia, Pulmonary embolism, Hypokalemia, Coronary 04
  • the apparatus may include a prompt button or for this list on the screen at this time so if it needs to be referenced again the user has easy access to it.
  • step 38(a) without IV / IO access, but with airway device confirmed, the apparatus communicates: Epinephrine 0.1 mg / kg ET in 5 ml NS (1:1,000; 0.1 ml / kg). The apparatus will then communicate: "Stop CPR and give five assisted ventilations”. Clock C is then set for 3 minutes.
  • the apparatus communicates: "Is the heart rate causing cardiopulmonary compromise or poor profusion?" If yes, go to pediatric step 43. If no, the apparatus prompts: QRS duration greater than 0.08 second? If yes, go to pediatric step 40. If not, then the apparatus communicates: "History compatible with sinus tachycardia or P waves present?" If yes, go to pediatric step 42. If no, go to pediatric step 41.
  • the apparatus communicates: "Possible ventricular tachycardia" and provides the following prompts: Consult pediatric cardiologist.
  • the apparatus communicates: "Possible SVT”. The apparatus prompts: Consult pediatric cardiologist.
  • the apparatus communicates: "Probable sinus tachycardia”.
  • the apparatus prompts: Consult pediatric cardiologist. Consider: Support ABC's with oxygen, IV line, pulse oximeter, monitor and defibrillator pads; May attempt fluid bolus; Search for etiologies
  • the apparatus prompts: QRS duration greater than 0.08 second? If yes, go to pediatric step 45. If not, then the apparatus communicates: "History compatible with sinus tachycardia or P waves present?" If no, go to pediatric step 44. If yes, the apparatus communicates: "Probable sinus tachycardia”.
  • the apparatus prompts: Consult pediatric cardiologist. Consider: Support ABC's with oxygen, IV line, pulse oximeter, monitor and attach defibrillator pads; May attempt fluid bolus; Search for etiologies.
  • the apparatus communicates: "Possible SVT”.
  • the apparatus prompts: Consult pediatric cardiologist.
  • the apparatus communicates: "Cardiovert at 0.5 to 1 Joule / kg”.
  • the apparatus prompts: May increase to 2 joules / kg if initial shock ineffective.
  • Vagal maneuvers Adenosine 0.1 mg /kg IV rapid bolus (max 1st dose 6 mg); May double and repeat dose once (max 2nd dose 12 mg); Support ABC's with oxygen, IV line, pulse oximeter, monitor and defibrillator pads.
  • step 45 (Wide-complex tachycardia / unstable), the apparatus communicates: "Possible ventricular tachycardia"
  • the apparatus prompts: Consider sedation then the apparatus communicates: "Cardiovert at 0.5 to 1 Joule / kg”.
  • the apparatus prompts: May increase to 2 joules / kg if initial shock ineffective.
  • Consult pediatric cardiologist Consider: Support ABC's with oxygen, IV line, pulse oximeter, monitor
  • the termination sequence is invoked.
  • the apparatus communicates: "Are you sure you want to end ACLS activities?" If yes, then the apparatus communicates: "Confirm you want to end ACLS activities?" If no, the loop continues.
  • the user is given an option to print a summary of events with the timing of drugs given relative to the external clocks and the internal elapsed time clock.
  • a sheet of paper having an adhesive back that can be inserted into the apparatus, printed on and then ejected from the apparatus.
  • the apparatus shall be adapted to provide audible and visual commands, prompts and reminders in a variety of languages.
  • An embodiment of the present invention includes a touch sensitive display providing navigation and selection of on-screen, graphical input elements, Input buttons providing program path / option selection, internal timer providing user prompts and program path selection. Further, an embodiment of the apparatus of the present invention is adapted to output the audio commands using speakers or other sound transducers.
  • the clocks that are presented to the responder can include lighted, segmented displays providing numeric time representation (digital clock) adapted to count-down, count-up, and timing for user actions within the program. Processing of the various commands within the CPU of the computer hardware includes customary computer operations. Subsequent actions within the program perform timing, prompting, and/or subsequent input functions. Subsequent prompts are displayed on the graphical display and are announced via the audio output.
  • Timing operations are performed by the program, and output via the segmented display. Subsequent user input for path selection, acknowledgement of user prompts within the program is accomplished via the input buttons and I or touch display.
  • the application software in which a method of the present invention is embodied is adapted to be stored within a computer hardware memory device, including a hard drive, RAM memory, or standard media, such as memory cards, flash memory devices, magnetic disks, optical disks, or other commonly used storage media.
  • Program updates including updates to ACLS algorithms, can be effected by over-writing obsolete code with new program files and/or program data on the memory media.
  • the form factor housing an embodiment of the present invention can include a rectangular cube housing, having front perforations with a speaker mounted within the housing behind the perforations, and aperture for receiving a touch sensitive graphical display, buttons protruding from the top near the front and segmented display protrudes from the top, facing front, near the back.

Landscapes

  • Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Critical Care (AREA)
  • Emergency Medicine (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Electrotherapy Devices (AREA)
EP06844282A 2005-11-12 2006-11-07 Fortschrittliches kardiales lebensunterstützendes gerät und verfahren Withdrawn EP1948302A2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73537105P 2005-11-12 2005-11-12
PCT/US2006/043404 WO2007058835A2 (en) 2005-11-12 2006-11-07 Advanced cardiac life support apparatus and method

Publications (1)

Publication Number Publication Date
EP1948302A2 true EP1948302A2 (de) 2008-07-30

Family

ID=38049126

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06844282A Withdrawn EP1948302A2 (de) 2005-11-12 2006-11-07 Fortschrittliches kardiales lebensunterstützendes gerät und verfahren

Country Status (4)

Country Link
EP (1) EP1948302A2 (de)
JP (1) JP2009515593A (de)
CA (1) CA2626931A1 (de)
WO (1) WO2007058835A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9119971B2 (en) 2012-07-26 2015-09-01 Zoll Medical Corporation Automated external defibrillator configuration
JP6796063B2 (ja) * 2014-11-14 2020-12-02 コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. 音波血栓溶解治療用超音波装置
US10665341B2 (en) 2015-03-30 2020-05-26 Zoll Medical Corporation Customer—or patient-based selective data encryption in medical device management
WO2016160851A1 (en) 2015-03-30 2016-10-06 Zoll Medical Corporation Customer-or patient-based selective data encryption in medical device management
US12159712B2 (en) 2015-03-30 2024-12-03 Zoll Medical Corporation Clinical data handoff in device management and data sharing
EP4489019A3 (de) 2015-03-30 2025-03-12 ZOLL Medical Corporation Verwaltung einer medizinischen vorrichtung
US11424024B2 (en) 2017-12-05 2022-08-23 Zoll Medical Corporation Medical equipment management
US11990230B2 (en) 2019-07-08 2024-05-21 Zoll Medical Corporation Management of medical equipment and responders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040214148A1 (en) * 2003-04-22 2004-10-28 Salvino Robert J. Updating health care protocols
US7930024B2 (en) * 2004-01-08 2011-04-19 Medtronic, Inc. Reducing inappropriate delivery of therapy for suspected non-lethal arrhythmias

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2007058835A3 *

Also Published As

Publication number Publication date
JP2009515593A (ja) 2009-04-16
CA2626931A1 (en) 2007-05-24
WO2007058835A2 (en) 2007-05-24
WO2007058835A3 (en) 2008-10-09

Similar Documents

Publication Publication Date Title
US20080125821A1 (en) Advanced cardiac life support apparatus and method
WO2007058835A2 (en) Advanced cardiac life support apparatus and method
US9168386B2 (en) Adaptation of the common notebook, laptop computer, netbook and tablet PC computer to enable each to be used as an automated external defibrillator (AED) to treat victims of sudden cardiac arrest
US10303852B2 (en) Decision support tool for use with a medical monitor-defibrillator
Koster et al. Part 5: Adult basic life support: 2010 International consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations
US7970464B2 (en) Method and system for responding to non-perfusing and non-shockable heart rhythms
US8594784B2 (en) Kits and methods for retrofitting and adapting common notebooks, laptop computers, and tablets, to enable each to be used as an automated external defibrillator (AED), and as a manual defibrillator
WO2008020369A1 (en) External defibrillators for analysis of multiple arrhythmia conditions
US20160171167A9 (en) Clinical dashboard for medical device
Jackson et al. Code blue: Do you know what to do?
US11806501B2 (en) Emergency medical intervention device
JP6509357B2 (ja) 高度除細動器用の適応臨床的利用プロファイル
US20180036545A1 (en) Defibrillation system for wall mounted point-of-care computers
MX2008005908A (en) Advanced cardiac life support apparatus and method
US20150223752A1 (en) Cardiac Emergency Response Facilitation Method and System
TWI844435B (zh) 電子裝置可讀取儲存媒體、救護提示輔助方法及其系統
Vaidyanathan Cardiopulmonary resuscitation–An updated review with guidelines
Ehntholt et al. Analysis of continuous arterial blood pressure using LUCAS-assisted CPR during in-hospital cardiac arrest
Veysman Shock me, tube me, line me
Nguyen et al. Resuscitation Emergencies
TWM651509U (zh) 醫療指導資訊系統
Guest et al. Fainting Spells
Cronkhite Jr Intracardiac Puncture in Cardiac Arrest: Multiple Episodes of Ventricular Asystole with Survival
CN112773977A (zh) 一种自动化注射泵
ANGELINI et al. Take It to Heart: How to Operate an Automated External Defibrillator

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20080609

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

R17D Deferred search report published (corrected)

Effective date: 20081009

RIC1 Information provided on ipc code assigned before grant

Ipc: A61H 31/00 20060101ALI20081203BHEP

Ipc: G09B 23/28 20060101AFI20081203BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20090603